PLA2G7 anticorps (AA 176-415)
Aperçu rapide pour PLA2G7 anticorps (AA 176-415) (ABIN6654171)
Antigène
Voir toutes PLA2G7 (Lp-PLA2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 176-415
-
Fonction
- PLA2G7 Antibody / Lp-PLA2 / PAFAH
-
Purification
- Antigen affinity purified
-
Immunogène
- Amino acids A176-N415 from the human protein were used as the immunogen for the PLA2G7 antibody.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal dilution of the PLA2G7 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- After reconstitution, the PLA2G7 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- PLA2G7 (Lp-PLA2) (Lipoprotein-Associated phospholipase A2 (Lp-PLA2))
-
Autre désignation
- PLA2G7
-
Sujet
- Lipoprotein-associated phospholipase A2 (Lp-PLA2), also known as platelet-activating factor acetylhydrolase (PAF-AH), is a phospholipase A2 enzyme that in humans is encoded by the PLA2G7 gene. Lp-PLA2 is a 45-50 kDa protein of 441 amino acids. It is one of several PAF acetylhydrolases. In the blood it travels mainly with low-density lipoprotein (LDL). Less than 20 % is associated with high-density lipoprotein HDL. It is an enzyme produced by inflammatory cells and hydrolyzes oxidized phospholipids in LDL. Lp-PLA2 is platelet-activating factor (PAF) acetylhydrolase, a secreted enzyme that catalyzes the degradation of PAF to inactive products by hydrolysis of the acetyl group at the sn-2 position, producing the biologically inactive products LYSO-PAF and acetate.
-
UniProt
- Q13093
-
Pathways
- Peptide Hormone Metabolism
Antigène
-